New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Three scientists, including one from the U.S., share the 2025 Nobel Prize in Chemistry for developing “metal-organic ...

Early clinical trial results show that serial brain biopsies reveal immune activity in brain cancer not captured by standard scans ...

Having knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding the disease, Dr. Fred R. Hirsch, Joe Lowe and Louis Price Professor of Medicine (Hematology and ...

The clinical and molecular heterogeneity of IBD—both between patients and within the same individual over time—continues to ...

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and ...

Chan Soon-Shiong Institute of Molecular Medicine at Windber has published the first proteogenomic study of breast cancers in ...

NanoCell Therapeutics, Inc. (“NanoCell”), a biotechnology company developing a non-viral, DNA-based in vivo gene therapy platform, today announced the appointments of Prof. Zoltán Ivics, PhD, Jens ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

(Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data from the prospective, randomized integral biomarker BALANCE trial (NCT03371719) finds that the PAM50 molecular signature ...

An experimental gene therapy was found to slow the progression of Huntington's disease, marking a major step toward a ...